Bacteriophage Therapy

BIOLOGICAL4 trials

Sponsors

Tsuruta Daisuke, Adaptive Phage Therapeutics, Inc., Queen Astrid Military Hospital

Conditions

Acne Vulgaris AcneBacterial InfectionsDiabetic Foot OsteomyelitisOsteomyelitisUrinary Tract Infection Bacterial

Phase 1

Bacteriophage Therapy in Patients With Urinary Tract Infections

TerminatedNCT04287478

Adaptive Phage Therapeutics, Inc.Urinary Tract Infection Bacterial

Start: 2020-12-09End: 2023-02-28Updated: 2023-03-03

Phase 2

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

TerminatedNCT05177107

Adaptive Phage Therapeutics, Inc.Diabetic Foot Osteomyelitis, Osteomyelitis

Start: 2021-11-24End: 2025-05-30Updated: 2025-08-19

The First Clinical Trial of Bacteriophage Therapy in Patients wtih Acne Vulgaris

Active, not recruitingJPRN-jRCTs051230164

Tsuruta DaisukeAcne Vulgaris Acne

Start: 2024-07-03Target: 15Updated: 2026-06-29

Unknown Phase

Bacteriophage Therapy of Difficult-to-treat Infections

CompletedNCT05498363

Queen Astrid Military HospitalBacterial Infections

Start: 2008-01-01End: 2021-12-31Updated: 2022-08-12

Related Papers

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

Nature Microbiology2024-06-04312 citations